StockWatch
·
Pharmaceuticals
Board Meeting22 Jul 2026, 04:40 pm

Lupin Ltd Board Meeting on Aug 6 to Approve Q1 FY27 Results

AI Summary

Lupin Ltd has announced that its Board of Directors will convene on August 6, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. Concurrently, the company has closed its trading window for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the results declaration, with the window set to re-open on August 9, 2026. This measure is in line with SEBI regulations and the company's insider trading code.

Key Highlights

  • Board meeting scheduled for August 6, 2026.
  • To approve Unaudited Standalone and Consolidated Financial Results.
  • Results are for the quarter ended June 30, 2026.
  • Trading window closed from July 1, 2026, to August 9, 2026.